Bone mass in ankylosing spondylitis

Clinical and Experimental Rheumatology

Volumn 18, Issue 5 SUPPL. 21, 2000, Pages

  Toussirot, E ^a   Wendling, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Ankylosing spondylitis; Bone mineral density; DEXA; Fractures

Indexed keywords

ACUTE PHASE PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIFEDIOL; CALCIUM; COLLAGEN; CORTICOSTEROID; CYTOKINE; DEOXYPYRIDINOLINE; ETIDRONIC ACID; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE; PYRIDINOLINE;

ABSORPTIOMETRY; ANKYLOSING SPONDYLITIS; BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE MARKER; FEMUR NECK; HUMAN; INFLAMMATION; LUMBAR SPINE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX RATIO; SPINE; SPINE MALFORMATION; VERTEBRA FRACTURE;

EID: 0033777172     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Diseases of the osseous system Case n°1
2. Spondylitis deformans: Its differential diagnosis and treatment by physical methods
3. Vertebral osteoporosis in ankylosing spondylitis
4. Radiological manifestations in 200 patients with ankylosing spondylitis: Correlation with clinical features and HLA B27
5. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis
6. Bone mineral density and vertebral compression fracture rate in ankylosing spondylitis
7. The prevalerce of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density
8. Bone mineral density in ankylosing spondylitis
9. Fracture risk in patients with ankylosing spondylitis: A population based study
10. Fractures of the thoracic and lumbar spine in ankylosing spondylitis
11. Spinal fractures complicating ankylosing spondylitis. A long term follow-up study
12. Bone mass in ankylosing spondylitis
13. Osteoporosis in early ankylosing spondylitis: A primary pathological event?
14. Appendicular and vertebra bone mass in ankylosing spondylitis. A comparison of plain radiographs with single and dual-photon absorptiometry and with quantitative computed tomography
15. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases
16. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis
17. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis
18. Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss
19. Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study
20. Bone mass, body composition and bone ultrasound measurements in ankylosing spondylitis
21. Spondylarthrite ankylosante et parametres phosphocalciques
22. Serum osteocalcin and vitamin D metabolites in patients with anky losing spondylitis
23. Evidence of impaired cartilage/none turnover in patients with ankylosing spondylitis
24. Biochemical markers of bone turnover in seronegative spondylarthropathy: Relationship to disease activity
25. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures
26. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis
27. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis
28. Absence of relation between TGFβ1 serum levels and bone mass in ankylosing spondylitis patients
29. Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis
30. Inhibitory effect of bone formation and calcification exercised by antiinflammatory drug ibuprofen
31. Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls
32. Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotrophin
33. Testosterone and testosterone free index in mild ankylosing spondylitis: Relationship with bone mineral density and vertebral fractures
34. The efficacy of etidronate on disease activity, markers of bone turnover and BMD in patients with early AS and osteoporosis
35. An open study of pamidronate in the treatment of refractory ankylosing spondylitis